James Chumbley Crouch, MD | |
911 Bypass Rd, Pikeville, KY 41501-1689 | |
(606) 218-3500 | |
(606) 437-1033 |
Full Name | James Chumbley Crouch |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 12 Years |
Location | 911 Bypass Rd, Pikeville, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215284062 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207LP2900X | Anesthesiology - Pain Medicine | MD459374 (Pennsylvania) | Secondary |
207LP2900X | Anesthesiology - Pain Medicine | 49104 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Elizabeth Florence | Florence, KY | Hospital |
St Elizabeth Edgewood | Edgewood, KY | Hospital |
St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
Dearborn County Hospital | Lawrenceburg, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anesthesia Group Practice Inc | 1254245137 | 361 |
Anesthesia Group Practice Inc | 1254245137 | 361 |
News Archive
Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.
When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist.
Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.
Many failing NHS hospitals across the UK will be bailed out by the taxpayer in a £5 billion rescue mission, according to a leading figure.
› Verified 5 days ago
Entity Name | Pikeville Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.
When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist.
Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.
Many failing NHS hospitals across the UK will be bailed out by the taxpayer in a £5 billion rescue mission, according to a leading figure.
› Verified 5 days ago
Entity Name | Anesthesia Group Practice Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417951948 PECOS PAC ID: 1254245137 Enrollment ID: O20151204001398 |
News Archive
Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.
When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist.
Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.
Many failing NHS hospitals across the UK will be bailed out by the taxpayer in a £5 billion rescue mission, according to a leading figure.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
James Chumbley Crouch, MD P.o. Box 432, Pikeville, KY 41502-0432 Ph: (606) 218-3500 | James Chumbley Crouch, MD 911 Bypass Rd, Pikeville, KY 41501-1689 Ph: (606) 218-3500 |
News Archive
Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.
When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist.
Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.
Many failing NHS hospitals across the UK will be bailed out by the taxpayer in a £5 billion rescue mission, according to a leading figure.
› Verified 5 days ago
Matthew Sexton, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-1033 | |
Michael Albert Mcclain, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 | |
Dr. William E Duvall, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-1033 | |
Kellie J Stivers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 | |
Dr. Philip S. Koerper, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-218-4562 | |
Dr. John Stuart Puckett, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 |